Assignee
AGENNIX INC
US16 patents
Top patents by PatentIndex Score
US6080559AJun 27, 2000
Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
AGENNIX INC46 citations95
US5955316ASep 21, 1999
Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
AGENNIX INC50 citations95
US7238661B2Jul 3, 2007
Oral lactoferrin in the treatment of respiratory disorders
AGENNIX INC18 citations92
US7420033B2Sep 2, 2008
Composition of lactoferrin related peptides and uses thereof
AGENNIX INC32 citations91
US7183381B2Feb 27, 2007
Composition of lactoferrin related peptides and uses thereof
AGENNIX INC28 citations91
US6399570B1Jun 4, 2002
Antimicrobial/endotoxin neutralizing polypeptide
AGENNIX INC32 citations91
US7524814B2Apr 28, 2009
Lactoferrin compositions and methods of wound treatment
AGENNIX INC11 citations82
US7323443B2Jan 29, 2008
Lactoferrin in the reduction of pain
AGENNIX INC9 citations82
US7026295B2Apr 11, 2006
Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
AGENNIX INC12 citations81
US8030272B2Oct 4, 2011
Lactoferrin compositions and methods of wound treatment
AGENNIX INC5 citations72
US7244706B2Jul 17, 2007
Antimicrobial/endotoxin neutralizing polypeptide
AGENNIX INC9 citations72
US7034126B2Apr 25, 2006
Lactoferrin in the treatment of diabetes mellitus
AGENNIX INC9 citations72
US7592306B2Sep 22, 2009
Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
AGENNIX INC6 citations71
US7901879B2Mar 8, 2011
Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
AGENNIX INC2 citations57
US7262279B2Aug 28, 2007
Lactoferrin in the treatment of diabetes mellitus
AGENNIX INC1 citations51
US7638487B2Dec 29, 2009
Lactoferrin in the reduction of pain
AGENNIX INC0 citations50